Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis.

coronary angiography hemostasis percutaneous coronary intervention radial access radial artery occlusion

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
27 Nov 2022
Historique:
received: 11 11 2022
accepted: 23 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 12 12 2022
Statut: epublish

Résumé

Background: Simultaneous ulnar and radial artery compression (SURC) has emerged as a strategy to increase radial artery flow and mitigate radial artery occlusion (RAO) while achieving adequate hemostasis after transradial access (TRA), though its technical adoption has been limited worldwide. Methods: A systematic search of studies comparing SURC versus isolated radial artery compression after TRA for coronary angiography and/or intervention was performed. Data were pooled by meta-analysis using random-effects models. Odds ratios (OR) with relative 95% confidence intervals (CI) and standardized mean difference were used as measures of effect estimates. The primary endpoint was the occurrence of overall RAO. Results: A total of 6 studies and 6793 patients were included. SURC method as compared to isolated radial artery compression was associated with a lower risk of RAO both overall (OR 0.29; 95% CI, 0.13−0.61, p < 0.001; number needed to treat to benefit [NNTB] =38) and in-hospital (OR 0.28; 95% CI: 0.10 to 0.75; p = 0.01, NNTB = 36), with a reduced risk of unsuccessful patent hemostasis (OR: 0.13; 95% CI: 0.02 to 0.85; p = 0.03, NNT = 5) and upper extremity pain (OR: 0.48; 95% CI: 0.24 to 0.95; p = 0.04, NNTB = 124). No significant difference was observed in hemostasis time and in the risk of hematoma. Conclusion: Compared to isolated radial artery compression, SURC is associated with lower risk of RAO, unsuccessful patent hemostasis, and reported upper limb pain, without any trade-off in safety outcomes. With further development of dedicated dual compression devices, the proposed technique should be freed from usage constraints.

Identifiants

pubmed: 36498587
pii: jcm11237013
doi: 10.3390/jcm11237013
pmc: PMC9739321
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Catheter Cardiovasc Interv. 2016 Apr;87(5):868-74
pubmed: 26269451
J Clin Epidemiol. 2008 Jan;61(1):64-75
pubmed: 18083463
Cardiovasc Revasc Med. 2019 Aug;20(8):674-677
pubmed: 30245153
J Clin Med. 2019 Oct 18;8(10):
pubmed: 31635342
Circ Cardiovasc Interv. 2018 Sep;11(9):e000035
pubmed: 30354598
Catheter Cardiovasc Interv. 2022 Sep;100(3):387-391
pubmed: 35842777
JACC Cardiovasc Interv. 2016 Oct 10;9(19):1992-1999
pubmed: 27712733
Int J Cardiol. 2022 Sep 15;363:23-29
pubmed: 35714715
J Interv Cardiol. 2018 Dec;31(6):949-956
pubmed: 30168201
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
JACC Cardiovasc Interv. 2012 Jan;5(1):36-43
pubmed: 22230148
EuroIntervention. 2017 Aug 4;13(5):e549-e556
pubmed: 28218605
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
JACC Cardiovasc Interv. 2019 Nov 25;12(22):2235-2246
pubmed: 31753298
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Cardiovasc Diagn Ther. 2017 Jun;7(3):305-316
pubmed: 28567356
JACC Cardiovasc Interv. 2022 Nov 28;15(22):2297-2311
pubmed: 36423974
Circ Cardiovasc Interv. 2022 Apr;15(4):e011555
pubmed: 35317614
J Clin Epidemiol. 2008 Oct;61(10):991-6
pubmed: 18538991
Anesth Pain Med (Seoul). 2021 Apr;16(2):138-150
pubmed: 33940767
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
J Am Heart Assoc. 2016 Jan 25;5(1):
pubmed: 26811162
J Invasive Cardiol. 2020 Dec;32(12):476-482
pubmed: 32961529
J Biopharm Stat. 2005;15(5):823-38
pubmed: 16078388
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):177
pubmed: 24740579
Medicine (Baltimore). 2015 Dec;94(52):e2170
pubmed: 26717360
J Clin Med. 2018 Oct 02;7(10):
pubmed: 30279350
J Invasive Cardiol. 2016 Nov;28(11):451-454
pubmed: 27529655
JACC Cardiovasc Interv. 2022 May 23;15(10):1022-1029
pubmed: 35589232

Auteurs

Francesco Condello (F)

Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.
IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Michele Cacia (M)

Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.
IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Matteo Sturla (M)

Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.

Riccardo Terzi (R)

IRCCS Ospedale Galeazzi-Sant'Ambrogio, University Cardiology Department, 20157 Milan, Italy.

Jorge Sánz-Sanchez (J)

Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.

Bernhard Reimers (B)

IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Gabriele L Gasparini (GL)

IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Paolo Pagnotta (P)

IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Sabato Sorrentino (S)

Center for Cardiovascular Research, Magna Graecia University, 88100 Catanzaro, Italy.
Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.

Carmen Spaccarotella (C)

Division of Cardiology, Department of Advanced Biomedical Science, Federico II University, 80138 Naples, Italy.

Ciro Indolfi (C)

Center for Cardiovascular Research, Magna Graecia University, 88100 Catanzaro, Italy.
Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.

Alberto Polimeni (A)

Center for Cardiovascular Research, Magna Graecia University, 88100 Catanzaro, Italy.
Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.

Classifications MeSH